K Pharma,Inc. Logo

K Pharma,Inc.

4896 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区六本木七丁目7番7号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

K Pharma, Inc. is a pioneering Japanese biotechnology company focused on transforming healthcare through innovative applications of iPS cell technology. Established as a spin-off from the Keio University School of Medicine, the company leverages groundbreaking research from esteemed professors in physiology and orthopedic surgery. K Pharma specializes in two main areas: iPS drug discovery, utilizing disease-specific iPS cells to develop targeted treatments, and regenerative medicine, aimed at creating therapies for spinal cord injuries and cerebral infarctions. With a mission to bring hope to patients worldwide, K Pharma is committed to advancing medical science and improving patient outcomes through its cutting-edge research and development initiatives.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for K Pharma,Inc.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-28 02:01
Regulatory News Service
臨時報告書
Japanese 24.2 KB
2025-03-28 02:00
Regulatory News Service
内部統制報告書-第8期(2024/01/01-2024/12/31)
Japanese 22.4 KB
2025-03-28 02:00
Annual Report
有価証券報告書-第8期(2024/01/01-2024/12/31)
Japanese 1.5 MB
2025-03-28 02:00
Regulatory News Service
確認書
Japanese 8.8 KB
2024-08-14 08:00
Regulatory News Service
確認書
Japanese 8.9 KB
2024-08-14 08:00
Interim Report
半期報告書-第8期(2024/01/01-2024/12/31)
Japanese 182.0 KB
2024-05-14 02:00
Quarterly Report
四半期報告書-第8期第1四半期(2024/01/01-2024/03/31)
Japanese 136.5 KB
2024-05-14 02:00
Regulatory News Service
確認書
Japanese 8.8 KB
2024-03-29 02:30
Regulatory News Service
臨時報告書
Japanese 22.6 KB
2024-03-28 07:01
Regulatory News Service
確認書
Japanese 8.8 KB
2024-03-28 07:00
Regulatory News Service
内部統制報告書-第7期(2023/01/01-2023/12/31)
Japanese 22.4 KB
2024-03-28 07:00
Annual Report
有価証券報告書-第7期(2023/01/01-2023/12/31)
Japanese 1.5 MB
2023-11-13 07:01
Regulatory News Service
確認書
Japanese 8.8 KB
2023-11-13 07:00
Quarterly Report
四半期報告書-第7期第3四半期(2023/07/01-2023/09/30)
Japanese 151.5 KB
2023-10-17 02:33
Regulatory News Service
臨時報告書
Japanese 21.9 KB

Automate Your Workflow. Get a real-time feed of all K Pharma,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for K Pharma,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK